Nutanix
Valuation each multiple against its own 5-year range
Vs. peers Software - Infrastructure
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Nutanix (NTNX) | 14.79B | 10.49 | 21.05 | 0.00% |
| Microsoft (MSFT) | 3.60T | 25.30 | 7.65 | 0.75% |
| Palantir (PLTR) | 345.74B | 101.05 | 30.79 | 0.00% |
| Oracle (ORCL) | 305.97B | 15.86 | 4.95 | 1.98% |
| Palo Alto Networks (PANW) | 281.87B | 686.64 | 9.83 | 0.00% |
| CrowdStrike (CRWD) | 234.93B | 6,037.89 | 46.05 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 11.8% below Morningstar's fair value estimate.
Fair value
Nutanix Inc receives a 4-star quantitative star rating, illustrating our stance that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 6% discount to our quantitative fair value estimate of $60.60 per share, which is reinforced by this estimate's low uncertainty rating.
The firm's solid growth bolsters our estimated valuation. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. For example, the firm's EBITDA per share growth sits in the top 40% compared with peers globally. This suggests rapid margin expansion is underway, or new markets are being tapped, which contributes to our view that shares are undervalued.
On a different note, the company's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 4.3%, a core component of valuation, ranks in the bottom 10% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.
Nutanix discussion 0 comments